AACT

Julius Clinical Research is a founding member of the Academic Alliance for Clinical Trials (AACT). The AACT effectively brings together academic contract research organisations in Europe, North and South America, Asia and the Pacific, to offer their expertise and networks in full service innovative trial design and execution of multinational clinical trials.

 

The AACT is a consortium of three major academic research institutions with a global network of collaborating clinical centers:

 

• Europe/ South America:	Julius Clinical Research,
	the Netherlands;
• North America:	MMRF Berman Center for Outcomes and Clinical Research and
	the Coordinating Center for Biometric Research,
	University of Minnesota, Minneapolis, USA;
• Asia-Pacific:	The George Institute for International Health,
	University of Sydney, Sydney, Australasia and
	Peking University, Beijing, China.

 

One of the competitive advantages of the AACT relative to ad-hoc Academic Research Organisation (ARO) collaborations is a harmonised quality system and a full set of SOPs.
Furthermore, the AACT provides sponsors access to a global network of more than 1.000 experienced clinical research sites and academic coordinating centers in five continents.
The AACT partners have more than 20 years of experience in pivotal clinical trials and the AACT successfully conducted more than 30 large scale clinical trials involving over 150.000 participants. Trials were conducted across Americas, Europe, Asia, Australasia and Africa using established research networks. The AACT has managed the two largest diabetes studies ever conducted (ADVANCE and ACCORD). The outcomes of clinical studies executed by the AACT had impact on clinical guidelines, including those for hypertension, dyslipidemia, coronary heart disease, heart failure, cerebrovascular disease and HIV/AIDS. The focus of the AACT lies on Cardiovascular, Diabetes & Metabolic disorders, Psychiatric disease, Infectious diseases and Vaccination.
The AACT published more than 1.000 publications in leading scientific journals.

The AACT, a global alliance between academic research centers and clinical networks, enables sponsors to complete major clinical trials that require site management in different regions worldwide by combining their clinical networks. Partners in the AACT value their academic roots and aim at providing academic added value while being able to perform research according to CRO industry standards.

 

Study	Participants	Study	Participants
CPCRA	25.000	SHARP	1.600
PEP	17.000	RENAL	1.500
CONVINCE	16.602	ACCORD	1.250
MRFIT	12.866	ARYA	1.012
EUROPA	12.218	ADDITION	1.000
ADVANCE	11.140	CAMELIA	1.000
LIPID	9.000	ASPECT 2	999
ONTARGET	8.000	TOMHS	902
SAFE	7.000	OPAL	750
ARTI-2	6.000	PACIFIC	750
PROGRESS	6.000	PART 2	700
NICE	6.000	UHFO	700
ESPRIT	4.150	China SSS	600
LIFT	4.000	PINE	598
ALLHAT	3.655	EUFEST	498

 

List of major studies co-ordinated by the leadership of the AACT.

 

 

 

  Global Presence of the AACT.